Financial Management Professionals’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2
| Closed | – | – | 1023 |
|
|
2024
Q3 | $0 | Sell |
2
-1
| -33% | – | ﹤0.01% | 1003 |
|
|
2024
Q2 | $0 | Buy |
3
+1
| +50% | – | ﹤0.01% | 981 |
|
|
2024
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 1035 |
|
|
2023
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 1013 |
|
|
2023
Q3 | $0 | Buy |
+2
| New | – | ﹤0.01% | 993 |
|
|
2023
Q2 | – | Sell |
-34
| Closed | -$3K | – | 1045 |
|
|
2023
Q1 | $3K | Buy |
34
+31
| +1,033% | +$2.74K | ﹤0.01% | 763 |
|
|
2022
Q4 | $0 | Buy |
3
+1
| +50% | – | ﹤0.01% | 1025 |
|
|
2022
Q3 | $0 | Sell |
2
-10
| -83% | – | ﹤0.01% | 1046 |
|
|
2022
Q2 | $1K | Sell |
12
-10
| -45% | -$833 | ﹤0.01% | 856 |
|
|
2022
Q1 | $2K | Buy |
+22
| New | +$2K | ﹤0.01% | 792 |
|